Neonatal cyanosis: exploring the complexity of coexisting congenital methemoglobinaemia and pulmonary hypertension (2026)

Peer-Reviewed Study · Sliskovic K, Aljughaiman A, Al Farsi A, Cheng A, Bhattacharya S · May 19, 2026

Sliskovic K et al., 2026-05-19: Case report of a newborn with cyanosis and pulmonary hypertension whose methemoglobinemia did not respond to methylene blue, leading to the diagnosis of a haemoglobin variant.

Possible triggering drugs were stopped and methylene blue was given without effect, prompting testing for haemoglobin variants.

Sliskovic K et al., 2026-05-19: Case report of a newborn with cyanosis and pulmonary hypertension whose methemoglobinemia did not respond to methylene blue, leading to the diagnosis of a haemoglobin variant. C4 (limits of methylene blue). Study type: single case report (BMJ Case Reports 2026), N=1, term male neonate, Western University, London, Ontario, Canada. MetHb 16.2%; methylene blue given without effect; haemoglobin-variant testing followed; MetHb fell and pulmonary pressures normalised by day 4; discharged day 22. Dose not stated in the abstract. PARTLY SUPPORTS C4: a congenital case (haemoglobin F-M-Fort Ripley variant, not reductase deficiency) in which methylene blue had no effect. Funder/conflicts not stated in the PubMed record. Study type: case report.